Carcinoma, Non-Small-Cell Lung Clinical Trials

Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT07222566

Conditions: Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, +19 more
Locations: Pioneer Research Center Bullhead City, Arizona, United States

Ironwood Cancer & Research Centers Chandler, Arizona, United States

Ironwood Cancer & Research Centers Gilbert, Arizona, United States

Ironwood Cancer & Research Centers Glendale, Arizona, United States

View all 440 locations

View Trial Details

Recruiting

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT07154290

Conditions: Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Cancer Treatment Centers of America, Phoenix Goodyear, Arizona, United States

The City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States

Rush University Medical Center Chicago, Illinois, United States

University of Illinois Chicago Chicago, Illinois, United States

View all 15 locations

View Trial Details

Recruiting

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

NCT06623422

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Banner MD Anderson Cancer Center ( Site 0181) Gilbert, Arizona, United States

The University of Arizona Cancer Center - North Campus ( Site 0163) Tucson, Arizona, United States

Providence St. Jude Medical Center ( Site 0106) Fullerton, California, United States

VA Long Beach Healthcare System ( Site 0199) Long Beach, California, United States

View all 241 locations

View Trial Details

Recruiting

A Study of DM005 in Patients With Advanced Solid Tumors

NCT06515990

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +14 more
Locations: Henry Ford Cancer Institute Detroit, Michigan, United States

Sarah Cannon Research Institute at Mary Crowley Dallas, Texas, United States

NEXT Oncology Virginia Fairfax, Virginia, United States

Chris O'Brien Lifehouse Camperdown, New South Wales, Australia

View Trial Details

Recruiting

Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy

NCT06862869

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China

Affiliated Cancer Hospital and Institute of Guangzhou Medical University Guangzhou, China

Huai He Hospital of Henan University Kaifeng, Henan, China

Henan Provincial Chest Hospital Zhengzhou, Henan, China

View all 44 locations

View Trial Details

Recruiting

A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

NCT07230691

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: University Hospital Graz Graz, Austria

Klinikum Klagenfurt am Worthersee Klagenfurt, Austria

UZ Brussel Brussels, Belgium

UZ Antwerpen Edegem, Belgium

View all 80 locations

View Trial Details

Recruiting

A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer

NCT07227025

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: New York University Langone Medical Center New York, United States

Oncology Consultants Cancer Center Houston, Texas, United States

Virginia Cancer Specialists Fairfax, Virginia, United States

Princess Margaret Hospital Toronto, Ontario, Canada

View all 13 locations

View Trial Details

Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT06667076

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Southern Cancer Center, PC Daphne, Alabama, United States

Clearview Cancer Institute Huntsville, Alabama, United States

City of Hope Phoenix Goodyear, Arizona, United States

The Oncology Institute of Hope and Innovation Cerritos, California, United States

View all 203 locations

View Trial Details

Recruiting

A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC

NCT07586202

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Taipei Medical University Hospital Taipei, Taiwan

Princess Margaret Hospital Toronto, Ontario, Canada

West China Hospital Sichuan University Chengdu, China

Guangdong Provincial People's Hospital Guangzhou, China

View Trial Details

Recruiting

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

NCT04165798

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Banner MD Anderson Cancer Center ( Site 0001) Gilbert, Arizona, United States

City of Hope ( Site 0014) Duarte, California, United States

UCSF Medical Center at Mission Bay ( Site 0007) San Francisco, California, United States

Georgetown University ( Site 0036) Washington D.C., District of Columbia, United States

View all 47 locations

View Trial Details

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung trial results

Related conditions